HuagongsheHuagongshe Chemistry Print Report · For research reference only
Hydrogen Bromide → 5-cyclopropyl-4-(2,2-difluoroethoxy)-N-(2-(5-methyl-1,2,4-oxadiazol-3-yl)-1-(methylsulfonyl)propan-2-yl)picolinamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Hydrogen Bromide | HCID 260 | — |
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | 2-(5-Methyl-1,2,4-oxadiazol-3-yl)-1-methylsulfonyl-propan-2-amine | HCID 90203430 | — |
| Reactant | 5-Cyclopropyl-4-(2,2-difluoroethoxy)pyridine-2-carboxylic acid | HCID 90203530 | — |
| Product | 5-cyclopropyl-4-(2,2-difluoroethoxy)-N-(2-(5-methyl-1,2,4-oxadiazol-3-yl)-1-(methylsulfonyl)propan-2-yl)picolinamide | HCID 90204092 | — |
Reaction Steps
The title compound was synthesized in analogy to Example 112e, using 5-cyclopropyl-4-(2,2-difluoroethoxy)pyridine-2-carboxylic acid;hydrochloride (example 145d) and 2-(5-methyl-1,2,4-oxadiazol-3-yl)-1-methylsulfonyl-propan-2-amine;hydrobromide (enantiomer B) (example 125b) as starting materials and isolated (25 mg, 31%); MS (ESI, m/z): 445.3 (M+H+).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09409866B2 |
| Source dataset | uspto-grants-2016_08 |
| ORD ID | ord-6c1cf3c870274a6bb99b8513efb5ca68 |
| Source note | uspto-grants-2016_08 |